Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price target boosted by Royal Bank of Canada from $160.00 to $292.00 in a research note issued on Friday, The Fly reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 5.26% from the […]